Salk Institute for Biological Studies:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Salk Institute for Biological Studies - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9312
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Salk Institute for Biological Studies (Salk) is a research institute that offers biological research programs. The institute’s areas of research comprise aging and regenerative medicine, cancer biology, immune system biology, metabolism and diabetes, neuroscience and neurological disorders, and plant biology. Its research provides development of new therapies and treatments for diseases such as cancer, AIDS, Alzheimer’s disease, cardiovascular disorders, anomalies of brain, birth defects, diabetes and metabolism, gene therapy, plant biology, vision, and williams syndrome, among others. Salk offers education outreach programs that deliver research impact on human health. The institute operates research centers such as Salk Cancer Center, Crick-Jacobs Center, Helmsley Center for Genomic Medicine, Center for the Neurobiology of Vision and Center for Nutritional Genomics, among others. Salk is headquartered in San Diego, California, the US.

Salk Institute for Biological Studies – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Salk Institute for Biological Studies, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Salk Institute Enters into Agreement with Indivumed 10
Ipsen Extends Research Agreement with Salk Institute for Biological Studies 11
Licensing Agreements 12
Metacrine Enters into Licensing Agreement with Salk Institute for Biological Studies 12
StemCell Technologies Enters into Licensing Agreement with Salk Institute for BrainPhys 13
Mitobridge Enters into Licensing Agreement with Salk Institute for Biological Studies 14
Salk Institute for Biological Studies – Key Competitors 15
Salk Institute for Biological Studies – Key Employees 16
Salk Institute for Biological Studies – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Government and Public Interest 18
Oct 02, 2018: Salk’s Janelle Ayres receives nih pioneer award for novel approaches to infectious disease 18
Sep 20, 2018: Decoding the structure of an RNA-based CRISPR system 19
Sep 18, 2018: Tweaking cells’ gatekeepers could lead to new way to fight cancer 20
Sep 13, 2018: Research in yeast leads to serendipitous finding about a central nervous system disorder 21
Sep 05, 2018: The alchemy of healing: Researchers turn open wounds into skin 22
Aug 30, 2018: A master switch controls aggressive breast cancer 23
Aug 23, 2018: Salk’s donors give $48.5 million to support scientific innovation in FY18 25
Aug 21, 2018: Salk Institute receives $2 million for cancer research initiative 26
Jul 11, 2018: Janelle Ayres receives $1 million from W. M. Keck Foundation for infectious disease research 27
Jun 26, 2018: Salk researchers win five competitive grants for cancer research 28
May 18, 2018: Salk Institute receives $1.5 million for Alzheimer’s research from NANOS 30
Mar 14, 2018: CRISPR genetic editing takes another big step forward, targeting RNA 31
Mar 13, 2018: Molecule That Gives Energy-Burning Brown Fat Its Identity Could Lead To Drugs For Obesity 33
Sep 19, 2017: CPRIT awards $34M to UTSW for cancer research recruitment 34
May 30, 2017: Brain’s immune cells linked to Alzheimer’s, Parkinson’s, schizophrenia 36
Feb 14, 2017: Salk scientist awarded inaugural Sjoberg Prize for cancer breakthrough 38
Other Significant Developments 39
Oct 18, 2018: Brain cells called astrocytes have unexpected role in brain plasticity 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Key Facts 2
Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Salk Institute for Biological Studies, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Salk Institute for Biological Studies, Deals By Therapy Area, 2012 to YTD 2018 8
Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Salk Institute Enters into Agreement with Indivumed 10
Ipsen Extends Research Agreement with Salk Institute for Biological Studies 11
Metacrine Enters into Licensing Agreement with Salk Institute for Biological Studies 12
StemCell Technologies Enters into Licensing Agreement with Salk Institute for BrainPhys 13
Mitobridge Enters into Licensing Agreement with Salk Institute for Biological Studies 14
Salk Institute for Biological Studies, Key Competitors 15
Salk Institute for Biological Studies, Key Employees 16

List of Figures
Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Salk Institute for Biological Studies, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Salk Institute for Biological Studies:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MS&AD Insurance Group Holdings, Inc.:企業の戦略・SWOT・財務分析
    MS&AD Insurance Group Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary MS&AD Insurance Group Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Star Group LP (SGU):企業の財務・戦略的SWOT分析
    Summary Star Group LP (Star Group) formerly Star Gas Partners LP, is a distributor of home heating products and services. The company distributes and sells heating and air conditioning equipment, diesel fuel, gasoline, propane, and home heating oil. Star Group offers home security and plumbing, inst …
  • Women’s Choice Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析
    Summary Women's Choice Pharmaceuticals LLC (WCP) is a pharmaceutical company that provides branded prescription products for women’s health care and urology markets. The company’s products include fem pH, a therapeutic vaginal jelly that is used to promote and maintain vaginal acidity caused by diab …
  • Akers Biosciences Inc (AKER):医療機器:M&Aディール及び事業提携情報
    Summary Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. Its products include BreathScan alcohol detectors, CHUBE, METRO …
  • Nitto Denko Corp (6988):製薬・医療:M&Aディール及び事業提携情報
    Summary Nitto Denko Corp (Nitto) is a manufacturer of diversified material, which produces electrical insulating material, electronics, industrial and functional products by harnessing its core technologies such as polymer synthesis, and adhesive and coating technologies. The company offers a broad …
  • Chorus Aviation Inc.:戦略・SWOT・企業財務分析
    Chorus Aviation Inc. - Strategy, SWOT and Corporate Finance Report Summary Chorus Aviation Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Prakash Constrowell Limited:企業の戦略・SWOT・財務分析
    Prakash Constrowell Limited - Strategy, SWOT and Corporate Finance Report Summary Prakash Constrowell Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • E-CO Energi Holding AS:企業の戦略的SWOT分析
    E-CO Energi Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Howden Joinery Group Plc:企業の戦略・SWOT・財務情報
    Howden Joinery Group Plc - Strategy, SWOT and Corporate Finance Report Summary Howden Joinery Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • ACB Securities Co Ltd:企業の戦略的SWOT分析
    ACB Securities Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Athenex Inc (ATNX):製薬・医療:M&Aディール及び事業提携情報
    Summary Athenex Inc (Athenex), formerly Kinex Pharmaceuticals LLC, is a biopharmaceutical company focused on the discovery, development and commercialization novel medicines and cell therapies for the treatment of cancers. The company’s orascovery products candidates include oral formulations of pac …
  • Ig Group Holdings Plc
    Ig Group Holdings Plc - Strategy, SWOT and Corporate Finance Report Summary Ig Group Holdings Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Symphony Ltd:企業の戦略・SWOT・財務分析
    Symphony Ltd - Strategy, SWOT and Corporate Finance Report Summary Symphony Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Kobayashi Pharmaceutical Co Ltd (4967)-製薬・医療分野:企業M&A・提携分析
    Summary Kobayashi Pharmaceutical Co Ltd (Kobayashi) is a manufacturer and distributor of pharmaceutical, health and personal care products. The company offers OTC pharmaceuticals, oral hygiene products, deodorizing air fresheners, cooling gel sheets, sanitary products, household sundries, and body w …
  • Grupo Aval Acciones y Valores SA:企業の戦略・SWOT・財務情報
    Grupo Aval Acciones y Valores SA - Strategy, SWOT and Corporate Finance Report Summary Grupo Aval Acciones y Valores SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Air China Limited:戦略・SWOT・企業財務分析
    Air China Limited - Strategy, SWOT and Corporate Finance Report Summary Air China Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • The Broad Institute Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary The Broad Institute Inc (Broad Institute), a subsidiary of The Broad Foundation is a non-profit research organization that conducts genomic research for treatment of human diseases. The organization transforms medicine by utilizing systematic approaches in biological sciences, to speed up th …
  • Kokuyo Camlin Ltd (KOKUYOCMLN):企業の財務・戦略的SWOT分析
    Kokuyo Camlin Ltd (KOKUYOCMLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Idorsia Pharmaceutical Ltd (IDIA):製薬・医療:M&Aディール及び事業提携情報
    Summary Idorsia Pharmaceutical Ltd (Idorsia) is a manufacturer and developer of medicine that discovers, develops various therapies. The company provides pipeline portfolio such as investigational candidates targeted at the treatment of resistant hypertension, chronic insomnia, vasospasm, and system …
  • Domtar Corporation:企業の戦略・SWOT・財務情報
    Domtar Corporation - Strategy, SWOT and Corporate Finance Report Summary Domtar Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆